Serviceeinschränkungen vom 12.-22.02.2026 - weitere Infos auf der UB-Homepage

Treffer: Optimizing clinical scientific research:the cohort intervention random sampling study with historical controls

Title:
Optimizing clinical scientific research:the cohort intervention random sampling study with historical controls
Source:
de Klerk, N D, Berben, P B Q, van der Ven, M, Fransen, A F, van der Hout-van der Jagt, M B, Oei, S G, van Laar, J O H E & van den Heuvel, E R 2025, 'Optimizing clinical scientific research : the cohort intervention random sampling study with historical controls', Journal of Comparative Effectiveness Research, vol. 14, no. 11, e240168. https://doi.org/10.57264/cer-2024-0168
Publication Year:
2025
Document Type:
Fachzeitschrift article in journal/newspaper
File Description:
application/pdf
Language:
English
Relation:
info:eu-repo/semantics/altIdentifier/pmid/40955624; info:eu-repo/semantics/altIdentifier/pissn/2042-6305; info:eu-repo/semantics/altIdentifier/eissn/2042-6313
DOI:
10.57264/cer-2024-0168
Rights:
info:eu-repo/semantics/openAccess ; http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number:
edsbas.B28516F8
Database:
BASE

Weitere Informationen

Randomized controlled trials (RCTs) are regarded as the highest level of evidence in medical research, but RCTs also have their drawbacks. Over the years, several alternative study designs have been introduced to address these problems. However, many of the alternative designs are often regarded as inferior to RCTs or currently not suitable for widespread implementation due to, for example, ethical or statistical problems. Thus, there is a need for study designs that have the same level of validity as RCTs, but are also suitable for large-scale implementation. The cohort intervention random sampling study (CIRSS) with historical controls meets these requirements, by combining the strengths of abovementioned designs. The CIRSS with historical controls has the potential to optimize implementation of promising new treatments as fluidly and rapidly as possible, representing real-world clinical population. Further research is required to address the range of analyses, implementation, issues, barriers and facilitators and ethical questions related to CIRSS.